Anionic cyclometalated Pt(ii) and Pt(iv) complexes respectively bearing one or two 1,2-benzenedithiolate ligands

Cytotoxic Pt(II) complexes containing alizarin: a selective carrier for DNA metalation

Many efforts have been made in the last few decades to selectively transport antitumor agents to their potential target sites with the aim to improve efficacy and selectivity. Indeed, this aspect could greatly improve the beneficial effects of a specific anticancer agent especially in the case of orphan tumors like the triple negative breast cancer. A possible strategy relies on utilizing a protective leaving group like alizarin as the Pt(II) ligand to reduce the deactivation processes of the pharmacophore enacted by Pt resistant cancer cells. In this study a new series of neutral mixed-ligand Pt(II) complexes bearing alizarin and a variety of diamine ligands were synthesized and spectroscopically characterized by FT-IR, NMR and UV-Vis analyses. Three Pt(II) compounds, i.e., 2b, 6b and 7b, emerging as different both in terms of structural properties and cytotoxic effects (not effective, 10.49 ± 1.21 μM and 24.5 ± 1.5 μM, respectively), were chosen for a deeper investigation of the ability of alizarin to work as a selective carrier. The study comprises the in vitro cytotoxicity evaluation against triple negative breast cancer cell lines and ESI-MS interaction studies relative to the reaction of the selected Pt(II) complexes with model proteins and DNA fragments, mimicking potential biological targets. The results allow us to suggest the use of complex 6b as a prospective anticancer agent worthy of further investigations.

A new family of luminescent [Pt(pbt)2(C6F5)L]n+ (n = 1, 0) complexes: synthesis, optical and cytotoxic studies

Given the widely recognized bioactivity of 2-arylbenzothiazoles against tumor cells, we have designed a new family of luminescent heteroleptic pentafluorophenyl-bis(2-phenylbenzothiazolyl) PtIV derivatives, fac-[Pt(pbt)2(C6F5)L]n+ (n = 1, 0) [L = 4-Mepy 1, 4-pyridylbenzothiazole (pybt) 2, 4,4'-bipyridine (4,4'-bpy) 3, 1,2-bis-(4-pyridyl)ethylene (bpe) 4 (E/Z ratio: 90/10), 1,4-bis-(pyridyl)butadiyne (bpyb) 5, trifluoroacetate (-OCOCF3) 6] and a dinuclear complex [{Pt(pbt)2(C6F5)}2(μ-bpyb)](PF6)27, in which the trans ligand to the metalated C-(pbt) was varied to modify the optical properties and lipophilicity. Their photophysical properties were systematically studied through experimental and theoretical investigations, which were strongly dependent on the identity of the N-bonded ligand. Thus, complexes 1, 3 and 6 display, in different media, emission from the triplet excited states of primarily intraligand 3ILCT nature localized on the pbt ligand, while the emissions of 2, 5 and 7 were ascribed to a mixture of close 3IL'(N donor)/3ILCT(pbt) excited states, as supported by lifetime measurements and theoretical calculations. Irradiation of the initial E/Z mixture of 4 (15 min) led to a steady state composed of roughly 1 : 1.15 (E : Z) and this complex was not emissive at room temperature due to an enhanced intramolecular E to Z isomerization process of the 1,2-bis-(4-pyridyl)ethylene ligand. Complexes 1-3 and 6 showed excellent quantum yields for the generation of singlet oxygen in aerated MeCN solution with the values of ϕ(1O2) ranging from 0.66 to 0.86 using phenalenone as a reference. Cationic complexes 1-3 exhibited remarkable efficacy in the nanomolar range against A549 (lung carcinoma) and HeLa (cervix carcinoma) cell lines with notable selectivity relative to the non-tumorigenic BEAS-2B (bronchial epithelium) cells. In the A549 cell line, the neutral complex 6 showed low cytotoxicity (IC50: 29.40 μM) and high photocytotoxicity (IC50: 5.75) when cells were irradiated with blue light for 15 min. These complexes do not show evidence of DNA interaction.

Platinum(IV) Complexes with Tridentate, NNC-Coordinating Ligands: Synthesis, Structures, and Luminescence

Platinum(II) complexes of NNC-cyclometalating ligands based on 6-phenyl-2,2'-bipyridine (HL¹) have been widely investigated for their luminescence properties. We describe how PtL¹Cl and five analogues with differently substituted aryl rings, PtL^2-6Cl, can be oxidized with chlorine and/or iodobenzene dichloride to generate Pt(IV) compounds of the form Pt(NNC-Lⁿ)Cl₃ (n = 1-6). The molecular structures of several of them have been determined by X-ray diffraction. These PtLⁿCl₃ compounds react with 2-arylpyridines to give a new class of Pt(IV) complex of the form [Pt(NNC)(NC)Cl]⁺. Elevated temperatures are required, and the reaction is accompanied by competitive reduction processes and generation of side-products; however, four examples of such complexes have been isolated and their molecular structures determined. Reaction of PtL¹Cl₃ with HL¹ similarly generates [Pt(NNC-L¹)₂]²⁺, which we believe to be the first example of a bis-tridentate Pt(IV) complex. The lowest-energy bands in the UV-vis absorption spectra of all the PtLⁿCl₃ compounds are displaced to higher energy relative to the Pt(II) precursors, but they red-shift with the electron richness of the aryl ring, consistent with predominantly ¹[π_Ar → π*_NN] character to the pertinent excited state. A similar trend is observed for the [Pt(NNC)(NC)Cl]⁺ complexes. They display phosphorescence in solution at room temperature, centered around 500 nm for [PtL¹(ppy)Cl]⁺ and [Pt(L¹)₂]²⁺, and 550 nm for methoxy-substituted derivatives. The lifetimes are in the microsecond range, rising to hundreds of microseconds at 77 K, consistent with triplet excited states of primarily ³[π_Ar → π*_NN] character with relatively little participation of the metal.

Curcumin-based ionic Pt(ii) complexes: antioxidant and antimicrobial activity

Four new Pt(ii) ionic complexes assembled from N-donor ligands and curcumin display interesting antioxidant and antimicrobial properties.

Brightly Luminescent Platinum Complexes of N∧C-∧N Ligands Forming Six-Membered Chelate Rings: Offsetting Deleterious Ring Size Effects Using Site-Selective Benzannulation

Brightly emissive platinum(II) complexes (λ_emission,max = 607-612 nm) of the type ^RLPtCl are reported, where ^RL is a cyclometalated N^∧C^-∧N-coordinating ligand derived from 1,3-di(2-trifluoromethyl-4-phenanthridinyl)benzene (^CF3LH) or 1,3-di(2-tert-butyl-4-phenanthridinyl)benzene (^tBuLH). Metathesis of the chlorido ligand can be achieved under mild conditions, enabling isolation of ionic compounds with the formula [^CF3LPtL']PF₆ where L' = pyridine or (4-dimethylamino)pyridine (DMAP), as well as the charge-neutral species ^tBuLPt(C≡C─C₆H₄─tBu) (C≡C─C₆H₄─tBu = 4-tert-butylphenylacetylido). Compared with N^∧N^∧N-ligated Pt(II) complexes that form 5-membered chelates, these compounds all contain 6-membered rings. Expanding the chelate ring size from 5 to 6 has been previously demonstrated to enhance emission in some N^∧N^∧N-coordinated Pt(II) species─for example, in complexes of 2,6-di(8-quinolinyl)pyridine vs those of 2,2':6',2″-terpyridine─but in related N^∧C^-∧N-coordinated species, luminescence quantum yields are significantly lower for the 6-membered chelate ring complexes. Here, we demonstrate that site-selective benzannulation of the quinolinyl side-arms can offset the deleterious effect of changing the chelate ring-size and boost photophysical properties such as the quantum yield. Density functional theory (DFT) and time-dependent DFT (TD-DFT) calculations suggest that benzannulation counterintuitively destabilizes the emissive triplet states compared to the smaller π-system, with the "imine-bridged biphenyl" form of the phenanthridinyl arm helping to buffer against larger molecular distortions, enhancing photoluminescence quantum yields up to 0.09 ± 0.02. The spontaneous formation under aerated conditions of a Pt(IV) derivative (^CF3LPtCl₃) is also reported, together with its molecular structure in the solid state.

Stable mixed-valence diphenylphosphanido bridged platinum(ii)-platinum(iv) complexes

The reaction between [NnBu4][(C6F5)2PtII(μ-PPh2)2PtIV(C^N)(I)2] (C^N = κ2-N,C-benzoquinolinate, 1) and (i) bidentate S^S, N^S and O^O anionic ligands or (ii) monodentate S- N- or O-based anionic ligands was studied in order to investigate the factors that may guarantee the stability of Pt(ii),Pt(iv) mixed-valence dinuclear phosphanido complexes. While reactions of 1 with S^S or N^S ligands afforded stable Pt(ii),Pt(iv) species of general formula [(C6F5)2PtII(μ-PPh2)2PtIV(C^N)(L^S)]x- [(L^S)(x-1) = 2-mercaptopyrimidinate (pymS-), 2-mercaptopyridinate (pyS-), dimethyldithiocarbamate (Me2NCS2-), ethyl xanthogenate (EtOCS2-) and 1,2-benzenedithiolate (PhS22-)], the reaction of 1 with the O^O ligand sodium acetylacetonate gave several products, and no pure Pt(ii),Pt(iv) complex could be isolated. The reaction of monodentate ligands such as PhS-, OH- or N3- with 1 led to a stable Pt(ii),Pt(iv) complex only in the case of N3-. The reaction with OH- afforded the Pt(ii),Pt(ii) complex [(C6F5)2PtII(μ-PPh2)(κ2-O,P-μ-O-PPh2)PtII(C^N)]- (8) deriving from reductive coupling of a diphenylphosphanide and an O-donor ligand coordinated to the Pt(iv) centre, while the reaction with PhS- produced the unstable Pt(ii),Pt(iv) complex [NnBu4][(C6F5)2PtII(μ-PPh2)2PtIV(C^N)(PhS)2] (11) that evolved in solution to the Pt(ii),Pt(ii) species [NnBu4][(C6F5)2PtII(μ-PPh2)2PtII(C^N)] (9) by elimination of diphenyldisulfide. Thus, the stability of mixed valence Pt(ii),Pt(iv) phosphanide complexes is affected by several concurrent factors, including the chelating effect of the ligands and the type of ligating atoms.

Anionic versus neutral Pt(II) complexes: The relevance of the charge for human serum albumin binding

The focus of this work is pointing out the different behavior of two structurally related Pt^(II) complexes, the anionic cyclometalated NBu₄[(Bzq)Pt(Thio)], 1 and the neutral [(Phen)Pt(Thio)], 2, (Bzq = benzo[h]quinoline, Phen = 1,10-phenantroline, Thio = 1,2-benzenedithiolate), on the interaction with human serum albumin (HSA), a key drug-delivery protein in the bloodstream. Being very limited the number of anionic Pt^(II) complexes reported to date, this is a pioneering example of report on a protein-ligand interaction involving a negatively charged platinum compound. The study was carried out by using fluorescence spectroscopy, differential scanning calorimetry and molecular docking simulations. The results revealed a strong binding affinity between the anionic compound and the protein, whereas a weak/moderate binding interaction was highlighted for the neutral one. Comparative studies with site specific ligands (warfarin and ibuprofen), allowed us to identify the protein binding sites of the two compounds. The work aims to shed light on the relevance of the charge in designing new drugs with a favorable binding affinity for HSA, which strongly contributes to influence their pharmacological and toxicological profile.